Bausch Health (BHC)
(Delayed Data from NYSE)
$8.03 USD
-0.15 (-1.83%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $8.02 -0.01 (-0.12%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Balance Sheet
Fiscal Year End for Bausch Health Cos Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 962 | 591 | 2,119 | 1,816 | 3,244 |
Receivables | 1,998 | 1,790 | 1,775 | 1,577 | 1,839 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,544 | 1,090 | 993 | 1,094 | 1,107 |
Other Current Assets | 1,092 | 776 | 720 | 855 | 779 |
Total Current Assets | 5,596 | 4,247 | 5,607 | 5,342 | 6,969 |
Net Property & Equipment | 1,707 | 1,600 | 1,598 | 1,567 | 1,466 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 2,101 | 2,166 | 2,252 | 2,137 | 1,690 |
Intangibles | 17,639 | 17,347 | 19,405 | 21,489 | 23,327 |
Deposits & Other Assets | 307 | 326 | 340 | 664 | 411 |
Total Assets | 27,350 | 25,686 | 29,202 | 31,199 | 33,863 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 719 | 521 | 407 | 337 | 503 |
Current Portion Long-Term Debt | 450 | 432 | 0 | 0 | 1,234 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3,133 | 2,988 | 4,791 | 4,576 | 4,511 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 4,302 | 3,941 | 5,198 | 4,913 | 6,248 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 163 | 202 | 529 | 528 | 705 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 21,938 | 20,334 | 22,654 | 23,925 | 24,661 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 1,029 | 949 | 855 | 1,228 | 1,113 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 27,432 | 25,426 | 29,236 | 30,594 | 32,727 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 10,423 | 10,391 | 10,317 | 10,227 | 10,172 |
Capital Surplus | 214 | 159 | 462 | 454 | 429 |
Retained Earnings | -9,778 | -9,186 | -8,961 | -8,013 | -7,452 |
Other Equity | -941 | -1,104 | -1,852 | -2,063 | -2,013 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -82 | 260 | -34 | 605 | 1,136 |
Total Liabilities & Shareholder's Equity | 27,350 | 25,686 | 29,202 | 31,199 | 33,863 |
Total Common Equity | -82 | 260 | -34 | 605 | 1,136 |
Shares Outstanding | 360.90 | 361.90 | 359.40 | 355.40 | 352.50 |
Book Value Per Share | -0.23 | 0.72 | -0.09 | 1.70 | 3.22 |
Fiscal Year End for Bausch Health Cos Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 623 | 755 | 962 | 780 | 588 |
Receivables | 2,102 | 2,048 | 1,998 | 1,948 | 1,743 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1,612 | 1,636 | 1,544 | 1,272 | 1,240 |
Other Current Assets | 874 | 957 | 1,092 | 1,048 | 890 |
Total Current Assets | 5,211 | 5,396 | 5,596 | 5,048 | 4,461 |
Net Property & Equipment | 1,738 | 1,713 | 1,707 | 1,584 | 1,599 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 2,187 | 2,149 | 2,101 | 2,189 | 2,191 |
Intangibles | 17,030 | 17,343 | 17,639 | 17,915 | 16,927 |
Deposits & Other Assets | 329 | 312 | 307 | 328 | 325 |
Total Assets | 26,495 | 26,913 | 27,350 | 27,064 | 25,503 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 579 | 642 | 719 | 569 | 515 |
Current Portion Long-Term Debt | 452 | 538 | 450 | 536 | 444 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3,338 | 3,225 | 3,133 | 3,119 | 3,008 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Total Current Liabilities | 4,369 | 4,405 | 4,302 | 4,224 | 3,967 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 170 | 170 | 163 | 213 | 215 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 21,208 | 21,536 | 21,938 | 21,894 | 20,108 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 975 | 1,029 | 968 | 942 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 26,722 | 27,087 | 27,432 | 27,299 | 25,232 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 10,483 | 10,480 | 10,423 | 10,420 | 10,412 |
Capital Surplus | 181 | 164 | 214 | 190 | 188 |
Retained Earnings | -9,832 | -9,842 | -9,778 | -9,739 | -9,361 |
Other Equity | -1,059 | -976 | -941 | -1,106 | -968 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | -227 | -174 | -82 | -235 | 271 |
Total Liabilities & Shareholder's Equity | 26,495 | 26,913 | 27,350 | 27,064 | 25,503 |
Total Common Equity | -227 | -174 | -82 | -235 | 271 |
Shares Outstanding | 361.30 | 366.80 | 360.90 | 365.20 | 364.30 |
Book Value Per Share | -0.63 | -0.47 | -0.23 | -0.64 | 0.74 |